{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T13:34:19Z","timestamp":1756992859433},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1987,1,1]],"date-time":"1987-01-01T00:00:00Z","timestamp":536457600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1987]]},"DOI":"10.1007\/bf00607569","type":"journal-article","created":{"date-parts":[[2004,11,25]],"date-time":"2004-11-25T05:09:32Z","timestamp":1101359372000},"page":"237-243","source":"Crossref","is-referenced-by-count":26,"title":["Haemodynamic, metabolic, and lymphocyte beta2-adrenoceptor changes following chronic beta-adrenoceptor antagonism"],"prefix":"10.1007","volume":"32","author":[{"given":"K.","family":"Whyte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. R.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. A.","family":"Howie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Deighton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. J.","family":"Sumner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. L.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1126\/science.847477","volume":"196","author":"DR Burt","year":"1977","unstructured":"Burt DR, Creese I, Snyder SH (1977) Antischizophrenic drugs: Chronic treatment elevates dopamine receptor binding in brain. Science 196: 326?327","journal-title":"Science"},{"key":"CR2","first-page":"1170","volume":"13","author":"JR Sporn","year":"1977","unstructured":"Sporn JR, Wolfe BB, Harden TK, Molinoff PB (1977) Supersensitivity in rat cerebral cortex: Pre and post synaptic effects of 6.0H dopamine at noradrenergic synapses. Mol Pharmacol 13: 1170","journal-title":"Mol Pharmacol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/280109a0","volume":"280","author":"KJ Catt","year":"1979","unstructured":"Catt KJ, Harwood JP, Aguilera G, Dufau ML (1979) Hormonal regulation of peptide receptors and target cell responses. Nature 280: 109?116","journal-title":"Nature"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/0024-3205(83)90262-X","volume":"33","author":"T Tenner","year":"1983","unstructured":"Tenner T (1983) Propranolol withdrawal induced supersensitivity to the chronotropic effects of isoproterenol in the conscious rabbit. Life Sci 33: 2291?2299","journal-title":"Life Sci"},{"key":"CR5","first-page":"622","volume":"3","author":"JG Webb","year":"1981","unstructured":"Webb JG, Newmann WH, Walle T, Daniell HB (1981) Myocardial sensitivity to isoproterenol following abrupt propranolol withdrawal in conscious dogs. J Cardiovasc Pharmacol 3: 622?635","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJM197508282930902","volume":"293","author":"RR Miller","year":"1975","unstructured":"Miller RR, Olson HG, Amsterdam EA, Mason DT (1975) Propranolol withdrawal rebound phenomena. N Engl J Med 293: 416","journal-title":"N Engl J Med"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0024-3205(78)90411-3","volume":"22","author":"E Hanski","year":"1977","unstructured":"Hanski E, Levitzki A (1977) The absence of desensitisation in the beta-adrenergic receptors of turkey reticulocytes and erythrocytes and its possible origin. Life Sci 22: 53?60","journal-title":"Life Sci"},{"issue":"2","key":"CR8","first-page":"439","volume":"221","author":"R Aarons","year":"1982","unstructured":"Aarons R, Molinoff PB (1982) Changes in the density of beta-adrenergic receptors in rat lymphocytes, heart and lung after chronic treatment with propranolol. J Pharmacol Exp Ther 221 [2]: 439?444","journal-title":"J Pharmacol Exp Ther"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1172\/JCI109781","volume":"65","author":"RD Aarons","year":"1980","unstructured":"Aarons RD, Nies AS, Gal J, Hegstrand LR, Molinoff PB (1980) Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol treatment. J Clin Invest 65: 949?957","journal-title":"J Clin Invest"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/0006-291X(77)90238-8","volume":"78","author":"G Glaubiger","year":"1977","unstructured":"Glaubiger G, Lefkowitz RJ (1977) Elevated beta-adrenergic receptor number after chronic propranolol treatment. Biochem Biophys Res Commun 78: 2","journal-title":"Biochem Biophys Res Commun"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1476-5381.1980.tb10689.x","volume":"68","author":"SP Baker","year":"1980","unstructured":"Baker SP, Potter LT (1980) Effects of propranolol in beta-adrenoceptors in rat hearts. Br J Pharmacol 68: 8?10","journal-title":"Br J Pharmacol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0014-2999(84)90089-X","volume":"107","author":"JR Peters","year":"1985","unstructured":"Peters JR, Nambi P, Sibley DR, Lefkowitz RJ (1985) Enhanced adenylate cyclase activity of turkey erythrocytes following treatment with beta-adrenergic receptor antagonists. Eur J Pharmacol 107: 43?52","journal-title":"Eur J Pharmacol"},{"issue":"Suppl 97","key":"CR13","first-page":"77","volume":"21","author":"A Boyum","year":"1968","unstructured":"Boyum A (1968) Isolation of mononuclear cells and granulocytes from blood by combining centrifugation and sedimentation. Scand J Clin Lab 21 [Suppl 97]: 77?89","journal-title":"Scand J Clin Lab"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/0024-3205(81)90490-2","volume":"29","author":"OE Brodde","year":"1982","unstructured":"Brodde OE, Engel G, Hoyer D, Bock ED, Weber F (1982) The beta adrenergic receptor in human lymphocytes. Subclassification by the use of a new radio ligand \u00b1125I- Iodo-cyanopindolol. Life Sci 29: 2189?2198","journal-title":"Life Sci"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0006-8993(84)91201-0","volume":"322","author":"CA Hamilton","year":"1984","unstructured":"Hamilton CA, Howie CA, Reid JL (1984) Changes in brain alpha-adrenoceptors with increasing age in rabbits. Brain Res 322: 177?179","journal-title":"Brain Res"},{"key":"CR16","first-page":"263","volume":"193","author":"OH Lowry","year":"1981","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RG (1981) Protein measurement of the Folin phenol reagent. J Biol Chem 193: 263?275","journal-title":"J Biol Chem"},{"key":"CR17","first-page":"483","volume":"4","author":"MA Lefevre","year":"1981","unstructured":"Lefevre MA, Girault J, Furtillan JB (1981) Measurements of plasma beta-blocker tissues. Beta-blocking agents determination of biological levels using high performance chromatography. Chromatography 4 (b): 483?500","journal-title":"Chromatography"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/0024-3205(76)90251-4","volume":"19","author":"M Prada Da","year":"1976","unstructured":"Da Prada M, Zurcher G (1976) Simultaneous radio-enzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. Life Sci 19: 1161?1174","journal-title":"Life Sci"},{"key":"CR19","volume-title":"Data analysis in rummage: A user's guide","author":"GR Bryce","year":"1980","unstructured":"Bryce GR (1980) Data analysis in rummage: A user's guide. Brigham Young University, Press, Utah"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/hrt.50.3.277","volume":"50","author":"AD Struthers","year":"1983","unstructured":"Struthers AD, Whitesmith R, Reid JL (1983) Metabolic and haemodynamic effects of increased circulatory adrenaline in man. Br Heart J 50: 277?281","journal-title":"Br Heart J"},{"key":"CR21","first-page":"807","volume":"4","author":"AJJ Wood","year":"1982","unstructured":"Wood AJJ, Feldman R, Nadeau J (1982) Physiological regulation of beta-receptors in man. Clin Exp Hypertens [A4]: 807?817","journal-title":"Clin Exp Hypertens"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/BF00692910","volume":"328","author":"OE Brodde","year":"1985","unstructured":"Brodde OE, Adau L, Stuka N, O'Hara N, Borchard U (1985) Effects of beta-adrenoceptor antagonist administration on beta2-adrenoceptor density in human lymphocytes. The role of intrinsic sympathomimetic activity. Naunyn-Schmiedebergs Arch Pharmacol 328: 417?422","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF00546700","volume":"26","author":"Y Giudicelli","year":"1984","unstructured":"Giudicelli Y, Lacasa D, Agli B, Lenevey B (1984) Comparison of changes in the characteristics of beta-adrenoceptors and responsiveness by human circulating lymphocytes during and after chronic administration of pindolol and propranolol. Eur J Clin Pharmacol 26: 7?12","journal-title":"Eur J Clin Pharmacol"},{"key":"CR24","first-page":"561","volume":"234","author":"A Hedberg","year":"1985","unstructured":"Hedberg A, Kempe F, Josephson ME, Molinoff PB (1985) Coexistence of beta1- and beta2-adrenergic receptors in the human heart. Effects of treatment with receptor antagonists. J Pharm Exp Ther 234: 561?568","journal-title":"J Pharm Exp Ther"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000138015","volume":"29","author":"L Piantanelli","year":"1984","unstructured":"Piantanelli L, Giunta S, Basso A, Cognin G, Paciaron A (1984) Atenolol induced regulation of leukocyte beta2-adrenoceptors in hypertension. Pharmacology 29: 210?214","journal-title":"Pharmacology"},{"key":"CR26","first-page":"261","volume":"2","author":"M Middeke","year":"1984","unstructured":"Middeke M, Remien J, Holzgreve H (1984) The influence of sex, age, blood pressure and stress on beta2-adrenoceptor density in mononuclear cells. J Hypertens 2: 261?263","journal-title":"J Hypertens"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"395s","DOI":"10.1111\/j.1365-2125.1982.tb01941.x","volume":"13","author":"RJ Walden","year":"1982","unstructured":"Walden RJ, Bhattacharjee P, Tomlinson B, Cashin J, Graham BR, Prichard BNC (1982) The effect of intrinsic sympathomimetic activity on beta-receptor responsiveness after beta-adrenoceptor blockade withdrawal. Br J Clin Pharmacol 13: 395s-364s","journal-title":"Br J Clin Pharmacol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1365-2125.1982.tb01442.x","volume":"13","author":"HH Vincent","year":"1982","unstructured":"Vincent HH, Man in 't Veld AJ, Boomsma F, Wenting GT, Schollenkamp MADH (1982) Elevated plasma noradrenaline in response to beta-adrenoceptor stimulation in man. Br J Clin Pharm Pharmacol 13: 717?721","journal-title":"Br J Clin Pharm Pharmacol"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF00569403","volume":"311","author":"AJ Kauman","year":"1980","unstructured":"Kauman AJ, Blinks JR (1980) Beta-adrenoceptor blocking agents, partial agonists in isolated heart muscle: Dissociation of stimulation and blockade. Naunyn-Schmiedebergs Arch Pharmacol 311: 237?248","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2125.1982.tb01942.x","volume":"13","author":"PB Molinoff","year":"1982","unstructured":"Molinoff PB, Aarons RD, Nies AS, Gerber BB, Wolfe, Goems MB (1982) Effects of pindolol and propranolol in beta-adrenergic receptors on human lymphocytes. Br J Clin Pharmacol 13: 365?366","journal-title":"Br J Clin Pharmacol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1146\/annurev.pa.20.040180.003053","volume":"20","author":"BB Hoffman","year":"1980","unstructured":"Hoffman BB, Lefkowitz RJ (1980) Radioligand binding studies of adrenergic receptors: New insights into molecular and physiological regulation. Ann Rev Pharmacol Toxicol 20: 561?600","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"CR32","first-page":"1","volume":"244","author":"RD Aarons","year":"1982","unstructured":"Aarons RD, Nies AS, Gerber JG, Molinoff PB (1982) Decreased beta-adrenergic receptor density in human lymphocytes after chronic treatment with agonists. J Pharmacol Exp Ther 244: 1?6","journal-title":"J Pharmacol Exp Ther"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"149s","DOI":"10.1111\/j.1365-2125.1982.tb01904.x","volume":"13","author":"J Clarke","year":"1982","unstructured":"Clarke J, Enninger KM, Bertholet A (1982) Pindolol ? the pharmacology of a partial agonist. Br J Clin Pharmacol 13: 149s-158s","journal-title":"Br J Clin Pharmacol"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00005344-198411000-00020","volume":"6","author":"HH Vincent","year":"1984","unstructured":"Vincent HH, Boomsa F, Man in 't Veld AJ, Derx FHM, Wonning GJ, Schollekamp MADH (1984) Effects of selective and non-selective beta-agonists on plasma, potassium and norepinephrine. J Cardiovasc Pharmacol 6: 107?114","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1042\/cs0650143","volume":"65","author":"AD Struthers","year":"1984","unstructured":"Struthers AD, Reid JL, Whitesmith R, Rodger JC (1984) The effects of cardioselective and non selective beta-adrenoceptor blockade in the hypokalemic and cardiovascular responses to adrenomedullary hormones in man. Clin Sci 65: 143?147","journal-title":"Clin Sci"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1056\/NEJM198312083092303","volume":"309","author":"MJ Brown","year":"1983","unstructured":"Brown MJ, Brown DC, Murphy MB (1983) Hypokalaemia from beta2-receptor stimulation by circulating epinephrine. N Engl J Med 309: 1414?1419","journal-title":"N Engl J Med"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00607569.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00607569\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00607569","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T03:24:02Z","timestamp":1554434642000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00607569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1987]]}},"alternative-id":["BF00607569"],"URL":"https:\/\/doi.org\/10.1007\/bf00607569","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987]]}}}